PAPADOPOULOS STELIOS
SEC CIK 1202098 · EDGAR
BoughtSold
Most active insiders at EXEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aftab Dana | EVP, Research, Development | — | $7.70M |
| 2 | Haley Patrick J. | EVP, Commercial | — | $7.60M |
| 3 | Smith Julie | Dir | — | $4.69M |
| 4 | WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| 5 | Senner Christopher J. | EVP, CFO | — | $4.56M |
| 6 | PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| 7 | POSTE GEORGE | Dir | — | $2.74M |
| 8 | Beckerle Mary C | Dir | — | $1.93M |
| 9 | Oliver Bob | Dir | — | $1.33M |
| 10 | Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 17:43 | 2026-05-27 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +8,367 | 1.20M | +0.7% | $0 | |
| 2026-04-09 17:15 | 2026-04-07 | OVID | Ovid Therapeutics Inc. | PAPADOPOULOS STELIOS | Dir | A - Grant | $2.56 | +17.6K | 217.6K | +9% | +$45.0K | |
| 2025-11-13 | 2025-11-12 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | S - Sale | $43.55 | -100.0K | 1.19M | -8% | -$4.36M | |
| 2025-05-30 | 2025-05-29 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +9,812 | 1.29M | +0.8% | $0 | |
| DM | 2025-05-16 | 2025-05-15 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | M - OptEx | $20.09 | +36.5K | 1.30M | +3% | +$733.4K |
| DM | 2025-05-16 | 2025-05-15 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | S - Sale+OE | $44.35 | -36.5K | 1.28M | -3% | -$1.62M |
| 2024-06-04 | 2024-05-31 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +18.8K | 1.28M | +1% | $0 | |
| D | 2024-05-22 | 2024-05-20 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | M - OptEx | $19.57 | +11.7K | 1.27M | +0.9% | +$228.7K |
| D | 2024-05-22 | 2024-05-20 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | S - Sale+OE | $21.00 | -11.4K | 1.26M | -0.9% | -$240.2K |
| 2023-06-02 | 2023-06-01 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +20.7K | 1.26M | +2% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +2,255 | 10.1K | +29% | $0 | |
| 2022-05-27 | 2022-05-26 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +19.6K | 1.24M | +2% | $0 | |
| 2022-02-24 | 2022-02-22 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Dir | S - Sale | $19.56 | -84.5K | 1.22M | -6% | -$1.65M | |
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +1,275 | 7,840 | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations